Epidermal growth factor receptor is involved in the development of an invasive phenotype in vulvar squamous lesions, but is not related to MIB-1 immunoreactivity

International Journal of Gynecological Pathology

Volumn 26, Issue 4, 2007, Pages 481-489

  Brustmann, Hermann ^a  

^a Thermenklinikum ^*  (Austria)

Author keywords

Epidermal growth factor receptor; MIB 1; Squamous cell carcinoma; Vulva

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; KI 67 ANTIGEN; MONOCLONAL ANTIBODY;

ARTICLE; BASAL CELL CARCINOMA; CELL DIFFERENTIATION; CONDYLOMA ACUMINATUM; CYTOPLASM; EPITHELIUM; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SQUAMOUS CELL CARCINOMA; VERRUCA VULGARIS; VULVA; VULVA SQUAMOUS LESION;

CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; CONDYLOMATA ACUMINATA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; NEOPLASM INVASIVENESS; PHENOTYPE; RECEPTOR, EPIDERMAL GROWTH FACTOR; VULVAR NEOPLASMS;

EID: 34748915801     PISSN: 02771691     EISSN: None     Source Type: Journal    
DOI: 10.1097/pgp.0b013e3180555999     Document Type: Article

References (32)

1. Creasman WT, Phillips H, Menck HR. The National Cancer Data Base report on early stage invasive vulvar carcinoma. Cancer 1997;80:505-13.
2. Lerma E, Matias-Guiu X, Lee SJ, et al. Squamous cell carcinoma of the vulva: study of ploidy, HPV, p53, and pRb. Int J Gynecol Pathol 1999;18:191-7.
3. Clement PB, Young RH: Malignant tumors of the vulva. In: Atlas of Gynecologic Surgical Pathology. Philadelphia, PA: Saunders, 2000:22-7.
4. Prat J. Pathology of vulvar intraepithelial lesions and early invasive carcinoma. Hum Pathol 1991;22:877-83.
5. Haefner HK, Tate JE, McLachlin CM, et al. Vulvar intraepithelial neoplasia: age, morphological phenotype, papillomavirus DNA, and coexisting invasive carcinoma. Hum Pathol 1995;26:147-54.
6. Toki T, Kurman RJ, Park JS, et al. Probable nonpapillomavirus etiology of squamous cell carcinoma of the vulva in older women: a clinicopathologic study using in situ hybridization and polymerase chain reaction. Int J Gynecol Pathol 1991;10:107-25.
7. Herbst RS. Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys 2004;59:21-6.
8. Alvarez G, Perry A, Tan BR, et al. Expression of epidermal growth factor receptor in squamous cell carcinomas of the anal canal is independent of gene amplification. Mod Pathol 2006;19:942-9.
9. Papouchado B, Erickson LA, Rohlinger AL, et al. Epidermal growth factor receptor and activated epidermal growth factor receptor expression in gastrointestinal carcinoids and pancreatic endocrine carcinomas. Mod Pathol 2005;18:1329-35.
10. Koretz K, Schlag P, Moller P. Expression of epidermal growth factor receptor in normal colorectal mucosa, adenoma, and carcinoma. Virchows Arch A Pathol Anat Histopathol 1990;416:343-9.
11. Itakura Y, Sasano H, Shiga C, et al. Epidermal growth factor receptor overexpression in esophageal carcinoma: an immunohistochemical study correlated with clinicopathologic findings and DNA amplification. Cancer 1994;74:795-804.
12. Ford AC, Grandis JR. Targeting epidermal growth factor receptor in head and neck cancer. Head Neck 2003;25:67-73.
13. Riese DJ Jr, Stern DF. Specificity within the EGF family/ErbB receptor family signaling network. Bioessays 1998;20:41-8.
14. Sporn MB, Roberts AB. Autocrine growth factors and cancer. Nature 1985;313:745-7.
15. Calvo E, Rowinsky EK. Clinical experience with monoclonal antibodies to epidermal growth factor receptor. Curr Oncol Rep 2005;7:96-103.
16. Steele RJ, Kelly P, Ellul P, et al. Epidermal growth factor receptor expression in colorectal cancer. Br J Surg 1990;77:1352-4.
17. Cunningham D, Humblet Y, Siena S, et al. Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer. N Engl J Med 2004;351:337-45.
18. Hart WR. Vulvar intraepithelial neoplasia: historical aspects and current status. Int J Gynecol Pathol 2001;20:16-30.
19. Wu X, Xin Y, Yao J, et al. Expression of epithelial growth factor receptor and its two ligands, transforming growth factor-alpha and epithelial growth factor, in normal and neoplastic squamous cells in the vulva: an immunohistochemical study. Med Electron Microsc 2001;34:179-84.
20. Johnson GA, Mannel R, Khalila M, et al. Epidermal growth factor receptor in vulvar malignancies and its relationship to metastasis and patient survival. Gynecol Oncol 1997;65:425-9.
21. Oonk MH, De Bock GH, Van der Veen DJ, et al. EGFR expression is associated with groin metastases in vulvar cancer, but does not improve their prediction. Gynecol Oncol 2007;104:109-13.
22. Hantschmann P, Lampe B, Beysiegel S, et al. Tumor proliferation in squamous cell carcinoma of the vulva. Int J Gynecol Pathol 2000;19:361-8.
23. Brustmann H, Naude S. Expression of topoisomerase IIα, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions. Gynecol Oncol 2002;86:192-9.
24. Niemiec J, Kolodziejski L, Dyczek S. EGFR LI and Ki-67 LI are independent prognostic parameters influencing survivals of surgically treated squamous cell lung cancer patients. Neoplasma 2005;52:231-7.
25. Ceccarelli C, Piazzi G, Paterini P, et al. Concurrent EGFr and Cox-2 expression in colorectal cancer: proliferation impact and tumour spreading. Ann Oncol 2005;16(Suppl 4):iv74-iv79.
26. Knauer DJ, Wiley HS, Cunningham DD. Relationship between epidermal growth factor receptor occupancy and mitogenic response. Quantitative analysis using a steady state model system. J Biol Chem 259:5623-31.
27. Lin SY, Makino K, Xia W, et al. Nuclear localization of EGF receptor and its potential new role as a transcription factor. Nat Cell Biol 2001;3:802-8.
28. Arteaga CL. Epidermal growth factor receptor dependence in human tumors: more than just expression? Oncologist 2002;7:31-9.
29. Woodworth CD, Michael E, Marker D, et al. Inhibition of the epidermal growth factor receptor increases expression of genes that stimulate inflammation, apoptosis, and cell attachment. Mol Cancer Ther 2005;4:650-8.
30. Hambek M, Solbach C, Schnuerch HG, et al. Tumor necrosis factor alpha sensitizes epidermal growth factor receptor (EGFR)-expressing carcinomas for anti-EGFR therapy. Cancer Res 2001;61:1045-9.
31. Zanchi C, Zuco V, Lanzi C, et al. Modulation of survival signaling pathways and persistence of the genotoxic stress as a basis for the synergistic interaction between the atypical retinoid ST1926 and the epidermal growth factor receptor inhibitor ZD1839. Cancer Res 2005;65:2364-72.
32. Leong TMY, Leong ASY. Controversies in the assessment of HER-2: more questions than answers. Adv Anat Pathol 2006;13:263-9.